toma evacuation) was studied using univariate and multivariable regression analyses. A nomogram based on multivariable analysis was formulated to predict severe hemorrhage risk for individual patients. Results: A total of 134 patients were identified with a mean treatment-free followup period of 2.1 years. bAVM ruptured in 83 (62%) children: 82 had a hemorrhage at presentation and 6 of them experienced a recurrent hemorrhage during follow-up; 1 patient had other diagnostic symptoms but bled during follow-up. Among them, 49% (41/83) had a severe hemorrhage; emergency hematoma evacuation was required in 28% of them (23/83), and 24% (20/83) remained as disabled (mRS ≥ 3) at last follow-up. Forty-six percent (38/82) of children with hemorrhagic presentation were severely disabled (mRS >3). Forty-three percent (3/7) were severely disabled after subsequent hemorrhage. The annual rate of severe subsequent hemorrhage was 1% in the overall cohort and 3.3% in children with ruptured presentation. All the subsequent severe hemorrhage events occurred in children with severe hemorrhage history (7%, 3/41). Periventricular location, non-temporal lobe location, and long draining vein were predictors for severe hemorrhage in pediatric untreated bAVMs. A no-
Introduction
Children with untreated brain arteriovenous malformations (bAVM) are at risk of experiencing life-threatening hemorrhage [1] . The primary aim of invasive treatment is to reduce unfavorable outcomes associated with bAVM rupture [2] . Recent studies suggest a lower morbidity of bAVM rupture than intracranial hemorrhage resulting due to other causes [3, 4] . Therefore, it might be more helpful for clinical decision-making if we can determine the morbidity of an untreated bAVM. However, most pediatric bAVMs present with hemorrhage, and conservative follow-up methods of ruptured bAVMs are scarce, making it difficult to assess long-term outcome in the natural course [1, 5] . Additionally, treatment-free time after hemorrhage varies between individuals, further hindering the comparison of clinical outcome. A recent study indicated that although intervention would change bAVM prognosis, the long-term outcome was still correlated with neurological function at presentation [6] . In addition, neurological evaluation immediately after the index event was more likely to reveal the actual impact of hemorrhage after bAVM rupture [3] . Therefore, an alternative approach to study the morbidity of bAVM might be to assess the immediate post-hemorrhage neurological function, which is the functional outcome at the same time point and it correlated with long-term prognosis.
A better understanding of the morbidity of bAVMs will also contribute to risk stratification of functional outcome. Previous reports identified posterior fossa, eloquent location, and associated aneurysm as potential predictors for severe hemorrhagic presentation in ruptured bAVM [7] . Our recent study in pediatric patients suggested a trend toward poorer neurological function at presentation and more emergency intervention in periventricular bAVM [8] . In this study with follow-up data before treatment, we aimed to (1) assess the neurological function after hemorrhagic presentation and subsequent hemorrhage and at follow-up in children with untreated bAVMs; (2) explore predictive features of severe hemorrhage in pediatric bAVM.
Materials and Methods
The study protocol was approved by the Institutional Review Board of our institution. Written informed consent was obtained from all participants and their guardians at the time of admission.
Patients and Study Design
The AVM database at our institution is a prospectively maintained database collecting demographic, clinical, and neuroradiological data for all patients with a confirmed angiographic or histological diagnosis of intracranial AVM treated at our institute [8] . This database was reviewed to identify all consecutive children diagnosed with bAVMs between July 2009 and December 2014. Pediatric patients were defined as patients who were 18 years of age or younger when angiographic diagnosis of bAVM (excluding dural and pial arteriovenous fistulas and vein of Galen malformations) was made for the first time.
bAVM hemorrhage was defined as a symptomatic clinical event with signs of fresh intracranial blood on CT or MRI and/or in the CSF with no easily identifiable alternative source that was more likely than the bAVM to be the cause. bAVM initial presentation and follow-up data before lesion-targeted treatment were evaluated. Neurological function was assessed using modified Rankin Scale (mRS) for children with age-specific modification as described previously (online suppl. Methods; for all online suppl. material, see www.karger.com/doi/10.1159/000458731) [9] . mRS scores were recorded within 24 h (1) after admission, (2) after subsequent hemorrhage, and (3) at follow-up before bAVM treatment [10] . A clinician who was not directly involved in the care of these patients performed all scale assessments. Considering the impact of varied follow-up time between presentation and treatment on neurological function, bAVM severe hemorrhage was defined as (1) mRS score >3 or (2) requiring emergency hematoma evacuation after hemorrhagic presentation or subsequent hemorrhage. Emergency hematoma evacuation was considered in patients with GCS ≤ 8 or large hematoma with midline shift. The annual hemorrhage/severe hemorrhage rate was calculated as the number of hemorrhages/severe hemorrhages divided by the total patient-years of treatment-free follow-up. For patients with conservative observation, this follow-up period was the interval between diagnosis and last follow-up. For patients who underwent interventional treatment, this period was from the time the diagnosis was made to the time of lesion-targeted treatment.
Neuroradiological Review MR, CT, and angiographic images were evaluated by consensus between 2 experienced neuroradiologists (J.M. and Gu Wei-Bin) who were blinded to the clinical information. A structured list of angiographic and MR features (location, size, venous drainage, and arterial supply) was retrospectively scored using a protocol that conformed to the consensus of bAVM research-reporting terminology recommended by a Joint Group [11] .
bAVM location was described as positive for frontal, temporal, parietal, occipital, basal ganglia, thalamus, internal capsule, corpus callosum, brain stem, and cerebellum, if bAVM nidus involved the aforementioned regions. Superatentorial bAVMs were further dichotomized as deep (basal ganglia, thalamus, internal capsule, and corpus callosum) and superficial (all other locations) [12] . A posterior fossa location was defined as brainstem, cerebellum, or both. Eloquent brain was defined as previously reported in the SpetzlerMartin grading system. bAVMs were also classified as periven-tricular location if the nidus (with a contrast-enhancement or flow void) contacted the ependymal lining of the ventricle on contrastenhanced T1-and T2-weighted images [8, 13] .
Venous drainage was dichotomized into exclusively deep venous drainage or non-exclusively deep venous drainage (superficial-only drainage or superficial and deep drainage). Long draining vein was defined as a draining vein with a length longer than 3 cm [14] . An aneurysm was defined as a saccular dilation of the lumen more than 2 times the width of the arterial vessel that carried the dilation [15] . Associated aneurysms only included aneurysms related to shunt flow [16] .
Each nidus was measured in 3 dimensions on the latest contrast-enhanced MRI and angiogram before bAVM rupture. The largest diameter (in millimeters) among the 3 dimensions was recorded as the maximal AVM size for further analysis.
Statistical Analysis
Data were analyzed using IBM SPSS Statistics version 22.0 (IBM, Armonk, NY, USA) and R software (version 3.3.1). Statistical significance was set at p < 0.05. For neuroradiological and clinical data, patients with and without severe hemorrhage were compared using descriptive statistics, including t test or Wilcoxon rank-sum test for continuous variables and χ 2 test or Fisher's exact test for categorical variables.
Both univariate and multivariable logistic regression were performed to estimate the risk of severe hemorrhage. We used 2 multivariable models to test the potential predictors that have been reported to be predictive of hemorrhage as listed in tables. Potential multi-collinearity and model fit were evaluated (online suppl. material). With the multivariable analysis, we formulated a nomogram to predict severe hemorrhage risk. Nomogram performance was assessed using the calibration curve and C-statistic to measure internal calibration and discriminative ability. C-statistic over 0.7 indicates a good model.
Results

Study Population
A total of 134 pediatric patients with bAVM were identified from among 889 patients with intracranial AVM ( Fig. 1 ; Table 1 ). The age at diagnosis ranged from 1 to 18 years (mean age 12 ± 3.9 years). None of the patients had familial bAVM or hereditary hemorrhagic telangiectasia. Ninety-four percent of bAVMs in this pediatric cohort were supratentorial. Thirty-seven percent were deep location and 47% involved the eloquent brain. Exclusively deep venous drainage was found in 10% of the bAVMs and long draining vein in 49%. Associated aneurysm was found in 10% of the children. Fifty-four percent of the bAVMs were Speztler-Martin grade I-II, 30% were grade III, and 16% were grade IV-V. Sixteen percent of cases were followed without interventional treatment.
Clinical Outcome after bAVM Hemorrhage and at Follow-Up before bAVM Treatment
In 82 children (82/134, 61%) with hemorrhage as initial presentation, the median delay between AVM rupture and initial neurological assessment was 1.5 days (mean 8 days). Among them, 46% (38/82) had an immediate post-hemorrhage mRS >3 and 28% of them (23/82) underwent emergency hematoma evacuation. A total of 41 patients (41/134, 31%) had a hemorrhagic presentation with severe neurological deficit (mRS >3) and/or requiring emergency intervention ( Fig. 1 , 2 ; Table 2 ).
Complete follow-up was obtained for all but 2 (1.5%) patients ( Fig. 1 ) . During a total follow-up period of 286.9 person-years between presentation and treatment (median 2.3 months, mean 2.1 years), 8 subsequent AVM hemorrhage events occurred in 7 patients, yielding an annual subsequent hemorrhage rate of 2.8%. One subsequent hemorrhage occurred in a child who had non-hemorrhagic presentation (annual rupture rate of 0.5% during 198.4 patient-years follow-up) and 7 hemorrhages reoccurred in 6 children with previous hemorrhagic presentation (annual re-bleeding rate of 7.9% during 88.5 patient-years follow-up). In children with conservative management, one subsequent hemorrhage occurred in a child after hemorrhagic presentation (annual rupture rate of 0.5%; Table 2 ).
Most children had a recurrent hemorrhage between the age of 8 and 13 years (mean age 10 ± 3.9 years, interquartile range [IQR] 8-13 years), and the median interval between 2 hemorrhagic events was 1.77 years (mean 2.6 ± 3.2 years, IQR 12 days-7 years). Among them, 3 children (3/7, 43%) had an immediate mRS >3 after bAVM rupture, who all had hemorrhagic presentation with mRS >3 ( Fig. 2 ) . No emergency hematoma evacuation was initiated and no child died after subsequent bleeding. The annual rate of severe subsequent hemorrhage was 1% in this pediatric cohort with bAVM, and 3.3% in children with ruptured presentation ( vere hemorrhage events occurred in children with severe hemorrhage history (7%, 3/41), although the present data did not identify a higher risk of future severe hemorrhage in children with severe hemorrhage history (OR 17.0; 95% CI 0.86-337.2). Subsequent hemorrhages tended to increase morbidity (median mRS 3, mean mRS 3.6 ± 1.1) compared with the hemorrhagic presentation (median mRS 3, mean mRS 3.4 ± 1.6), while the difference was not significant ( p = 0.69; Table 2 ).
The mRS score at treatment-free follow-up was determined before bAVM treatment or at last follow-up for those who were under conservative observation ( Table 2 ; Fig. 2 ). Twenty children (20/83, 24%) with ruptured bAVM had an mRS score ≥ 3 at follow-up. Neurological function at follow-up (median mRS 2, mean mRS 2.0 ± 1.2) was improved over time compared with mRS at hemorrhagic presentation (median mRS 3, mean mRS 3.4 ± 1.6). The mRS at follow-up was positively correlated with mRS at presentation ( R = 0.58, p < 0.001).
Morphologic Features Associated with Severe Hemorrhage
In univariate analysis, severe hemorrhage (mRS >3 or requiring emergency hematoma evacuation after hemorrhagic presentation or subsequent hemorrhage) occurred at a significantly higher frequency in bAVMs in periventricular location ( p = 0.003) and non-temporal lobe ( p = 0.03), whereas we did not find any association between other anatomical locations and severe hemorrhage. There was a trend for more severe hemorrhage to occur in bAVMs with long draining vein ( p = 0.06; Table 1 ).
Multivariable logistic analyses were performed to define independent risk factors for severe bAVM hemor- rhage using 2 models: a forward stepwise model to test all variables listed in Table 3 , excluding interactions between variables and a full model with all the variables entered, adjusting relative risks. In both of them, we identified periventricular location, non-temporal location, and long draining vein as predictors for severe hemorrhage. Age, gender, deep location, eloquent location, posterior fossa, exclusively deep venous drainage, and associated aneurysm did not have an effect in these pediatric patients. Along with the multivariable regression analysis, we used a nomogram to show the risk stratification for severe hemorrhage based on the morphology of bAVM ( Fig. 3 a) . For an individual patient, positive factors contributed to points and a total point corresponded to his probability of experiencing severe hemorrhage from an untreated bAVM. The calibration curve suggested that the nomogram was relatively well calibrated with minor discrepancies between observed and predicted probabilities ( Fig. 3 b) . C-statistic of 0.74 (95% CI 0.64-0.83) and 0.72 after bootstrap correction indicated good model discriminative ability. 
Discussion
bAVMs are described as the underlying cause of a majority of childhood intracranial hemorrhage, while the ARUBA trial comparing bAVM natural history risk and treatment risk did not include pediatric patients [1] . Recent studies suggest that bAVM rupture may be more benign than previously assumed, with a lower morbidity than intracranial hemorrhage from other causes [1, 3, 4] . Therefore, to understand the morbidity of spontaneous hemorrhage and to predict the risk of severe hemorrhage might be helpful for weighing risks from untreated bAVM and invasive treatment. In our pediatric cohort, we assessed the neurological function after the first and recurrent hemorrhages during treatment-free follow-up.
Morbidity of Pediatric bAVM Hemorrhage
Hospital-or population-based cohort studies revealed an overall case fatality of 11-29% and severe disability rate of 14-38% after bAVM hemorrhage in adults [3, 17] . In our pediatric cases, 42-46% of children were severely disabled after hemorrhagic presentation or subsequent hemorrhage, which is congruent with previous data of treated pediatric bAVM series (32-50%) [5, 6] . While some previous reports on bAVM patients of all ages suggested a lower rate of severe disability after incident hemorrhage (3-45%), however, a longer delay between bAVM rupture and neurological assessment might be one of the factors for the prevalence of lower rates in those studies ( Table 4 ) [3, 18] . Additionally, we only found a trend that showed that a mild higher mRS score was observed after hemorrhage in younger children ( Fig. 2 ; online suppl. material). Therefore, further observation is still required to determine whether the morbidity of bAVM rupture is correlated with age and whether it is different between children and adults.
During treatment-free follow-up, the annual rate of subsequent severe hemorrhage (overall 1.0%, conservative observation subgroup 0.5%) and annual rupture rate (2.8%) in this pediatric cohort ( Table 2 ) were similar to that quoted in other study of patients of all ages (severe hemorrhage rate of 1.4% and rupture rate of 2-4%) [19] [20] [21] . However, the cumulative rupture risk and morbidity could be high, given the long life expectancy of pediatric patients. Moreover, our follow-up data suggest that children with a severe hemorrhage history might be at higher risk for poor outcome after new hemorrhage. All the subsequent severe hemorrhage occurred in children with a severe hemorrhagic presentation during a short-term follow-up, while the treatment-free follow-up time was similar between children with or without severe hemorrhagic history (log-rank, p = 0.54, even shorter in children with severe hemorrhagic history, mean 1.3 vs. 2.5 years) ( Table 1 ; online suppl. material), suggesting that the risk of subsequent severe hemorrhage in children with severe hemorrhagic history might not be overestimated. Thus, pediatric bAVM patients with a severe hemorrhage history should be recommended to seek treatment for obliteration of the lesion. It should be noted that around 50% of pediatric bAVMs are not diagnosed until they rupture, and we observed subsequent hemorrhage only in one unruptured bAVM. Therefore, the morbidity of severe hemorrhage in unruptured bAVM still needs more studies. Another important functional outcome measurement is the disability at longer-term follow-up. Although we found that 76% of children with ruptured bAVM were independent (mRS <3) during follow-up (55-95% reported in patients of all ages) [3, 4, 18] , this should be interpreted with caution. Eighty-four percent of our cases underwent interventional treatment for the lesion, while the intervals between index event and treatment were individualized. In the presumably lower-risk subgroup of 21 conservatively managed patients, 73% of children with ruptured bAVM (8/11) were independent during followup. Interventional treatment might prevent a devastating outcome in some cases but censor follow-up of others in rehabilitation. However, a majority of patients with ruptured bAVM would be recommended for intervention considering a higher future hemorrhage risk. Therefore, it is relatively difficult to describe the long-term functional outcome after bAVM hemorrhage in a natural course.
Predictive Features for Severe Hemorrhage in Pediatric bAVM
Severe morbidity of bAVM hemorrhage could be influenced by hemorrhage risk and hemorrhage location and it involved brain function. Previous studies on the functional outcome of bAVM hemorrhage were mainly focused on ruptured bAVM, which excluded the effect of different hemorrhage risk among bAVM of various features ( Table 4 ) . Therefore, predictive factors identified in these studies might not be associated with severe hemorrhage in all bAVM patients. For instance, in ruptured bAVM, eloquent location is associated with severe hemorrhage. However, it is not a predictor for higher hemorrhage risk [22, 23] . In addition, the eloquence includes functional cortex, deep brain, and brain stem, while some important subcortical tracts are outside the scope of the definition. Compared with the cortex, tract injury seems to result in a more long-term neurological deficit, where the functional reorganization might be slow [24] .
In this study, we identified periventricular nidus location, non-temporal lobe location, and long draining vein as independent predictors for severe hemorrhage. The periventricular brain includes not only a vital structure in Table 4 . Clinical outcome of patients with untreated brain arteriovenous malformation after presenting and subsequent hemorrhages from different studies Hartmann [3] Choi [2] Majumdar [12] Current study 
